Showing results (211-220 of 350) with videos related to
Sort By:
Pageof 35
Emerging Infectious Diseases|April 6, 2018
Westward Spread of Highly Pathogenic Avian Influenza A(H7N9) Virus among Humans, ChinaQiqi Yang, Wei Shi, Lei Zhang, et al.Journal of Virology|January 25, 2008
Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population levelChristoph Neumann-Haefelin, David N Frick, Jing Jing Wang, et al.The Journal of Infectious Diseases|June 30, 2016
The Evolution and Transmission of Epidemic GII.17 NorovirusesJing Lu, Lin Fang, Huanying Zheng, et al.Emerging Infectious Diseases|September 19, 2018
Molecular Evolution, Diversity, and Adaptation of Influenza A(H7N9) Viruses in ChinaJing Lu, Jayna Raghwani, Rhys Pryce, et al.Journal of Virology|July 29, 2016
HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with CancerRebecca Rose, Susanna L Lamers, David J Nolan, et al.Alcoholism, Clinical and Experimental Research|March 22, 2007
Linkage disequilibrium and association analysis of alpha-synuclein and alcohol and drug dependence in two American Indian populationsJordi Clarimon, Rebecca R Gray, Lindsey N Williams, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 16, 2013
High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switchMattias Mild, Rebecca R Gray, Anders Kvist, et al.Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimesChadi M Saad-Roy, Sinead E Morris, C Jessica E Metcalf, et al.Biorxiv : the Preprint Server for Biology|June 2, 2021
Identification of evolutionary trajectories shared across human betacoronavirusesMarina Escalera-Zamudio, Sergei L Kosakovsky Pond, Natalia Martínez de la Viña, et al.Science (New York, N.Y.)|March 10, 2021
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimesChadi M Saad-Roy, Sinead E Morris, C Jessica E Metcalf, et al.Pageof 35